Andrew Reardon - Jun 28, 2024 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
Chief Legal Officer &
Signature
/s/ Andrew Reardon
Stock symbol
LGND
Transactions as of
Jun 28, 2024
Transactions value $
$19,973
Form type
4
Date filed
7/2/2024, 07:45 PM
Previous filing
May 13, 2024
Next filing
Aug 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Other $20K +329 +1.48% $60.71 22.5K Jun 28, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Ligand Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).